Median Technologies: Financial Communications Schedule for the First Half of 2020
20 Janvier 2020 - 5:45PM
Business Wire
Regulatory News:
Median Technologies (Paris:ALMDT), The Imaging Phenomics
Company® announces the publication date for its 2019 results:
Publication
Date
2019 results
April 14, 2020*
*Distribution after the close of trading
About Median Technologies: Median Technologies provides
innovative imaging solutions and services to advance healthcare for
everyone. We leverage the power of Imaging Phenomics to provide
insights into novel therapies and treatment strategies. Our unique
solutions for medical image analysis and management in oncology
trials and iBiopsy® for imaging phenotyping, together with our
global team of experts, are advancing the development of new drugs
and diagnostic tools to monitor disease and assess response to
therapy. Median Technologies supports biopharmaceutical sponsors
and healthcare professionals around the world to quickly and
precisely bring new treatments to patients in need. This is how we
are helping to create a healthier world.
Founded in 2002, based in Sophia-Antipolis, France, with a
subsidiary in the US and another one in Shanghai, Median has
received the label “Innovative company” by the BPI and is listed on
Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). For
more information: www.mediantechnologies.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200120005306/en/
Median Technologies Emmanuelle Leygues Head of Corporate
Communications +33 6 10 93 58 88
emmanuelle.leygues@mediantechnologies.com
Press - ALIZE RP Caroline Carmagnol +33 6 64 18 99 59
median@alizerp.com
Investors - ACTIFIN Ghislaine Gasparetto +33 1 56 88 11
11 ggasparetto@actifin.fr
Median Technologies (EU:ALMDT)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Median Technologies (EU:ALMDT)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024